ArticleEuropean urology2024

Re: Chimeric Antigen Receptor T Cells as Adjuvant Therapy for Unresectable Adenocarcinoma.

Rodrigo España-Navarro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.